AGP Executive Report
Last update: 6 minutes agoHemp Product Access: A 76-year-old says hemp gummies helped her insomnia and warns that federal restrictions due Dec. 11 could cut off access to products she relies on. Industry: eThekwini is advancing a three-year cannabis and hemp pilot to help local growers enter the formal market through training, quality genetics and regulatory guidance. Cannabinoid Research: Lab tests found cannabigerol’s anti-inflammatory effects on brain cells were inconsistent and dose-dependent, underscoring that early promise does not establish safety or benefit in people. Sleep Health: A long-term study found cannabis users had poorer objectively measured sleep, despite not reporting worse sleep themselves. Youth Health: A U.S. study found cannabis was involved in most substance-related emergency visits among adolescents and young adults, while alcohol predominated among older adults. Product Safety: A report says 86% of tested cannabis products lacked required label information, raising concerns about what consumers can learn from packaging.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
